共 25 条
- [1] Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP), 2012 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2013, 62 (07): : 131 - 135
- [2] Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine From the Advisory Committee on Immunization Practices, 2010 (Reprinted from MMWR, vol 60, pg 13-15, 2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (09): : 878 - 880
- [3] Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019 MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (03): : 77 - 83
- [4] FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Reprinted from MMWR, vol 60, pg 1279-1280, 2011) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (17): : 1856 - 1857
- [5] FDA Approval of Expanded Age Indication for a Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Reprinted from MMWR, vol 58, pg 374-375, 2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (08): : 841 - 841
- [9] Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP) (Reprinted from MMWR vol 40, pg 816, 2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (04): : 334 - 336
- [10] Notes From the Field: Use of Tetanus, Diphtheria, and Pertussis Vaccine (Tdap) in an Emergency Department-Arizona, 2009-2010 (Reprinted from MMWR, vol 61, pg 55-56, 2012) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 307 (16): : 1687 - 1688